Endoscopy · 2018 · 30 citations · 3 references
MedicineImmunologyOncologyGastrointestinal OncologyHepatologyImmunotherapyBiliary Tract DiseaseCancer ImmunotherapyGastrointestinal PathologyImmune-related Adverse Event ManagementImmune-related Adverse EventsLung CancerMedication-related Adverse EventsUlcerative Inflammation
Fig.
3
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Julie R. Brahmer, Karen L. Reckamp, Lucio Crinò et al. · New England Journal of Medicine · 2015 · 8.6K citations · Full text
Pharmacy, Oncology, Pharmacotherapy +15